Reading Time: 3 minutes Whilst we believe that there are currently around 5,000 adults in the UK living with MND at any one time, the precise figure is not known as there is no single source of information to confirm it. The MND Register of England, Wales and Northern Ireland is set to find a more accurate figure of the…
Reading Time: 2 minutes What is the MND Register? The MND Register is a major five year project that aims to collect and store information about every person living with MND in England, Wales and Northern Ireland. It is led by world-class MND researchers Prof Ammar Al-Chalabi and Prof Kevin Talbot, at a cost of £400,500 (our grant reference:…
Reading Time: 7 minutes Each year we invite plenary speakers who are experts in their fields to provide an overview on topics across MND research and clinical practice. This year we have 14 plenary speakers talking about ALS/MND who will discuss a wide range of topics from genetics to tissue biomarkers to improving clinical practice. In this second blog we will be taking a closer look at some of our plenary speakers this year and sharing more about the topics they will be discussing.
Reading Time: 7 minutes As the research team count down to this year’s International Symposium on ALS/MND, we will be posting blogs throughout November to give you a snapshot of some of the research being presented at this year’s event. This year marks the 34th Symposium, the largest scientific and medical conference specific to ALS/MND, and we are looking…
Reading Time: 7 minutes Clinical trials are vital in the hunt for effective treatments of motor neurone disease. They provide the evidence needed to determine whether a drug is safe and effective. In trials, participants are randomly assigned to receive either the treatment or a dummy drug, also known as a placebo. While this group is crucially important in…
Reading Time: 5 minutes The current pace of clinical trials means that there are now more trials testing potential drugs for MND in the UK than ever before. One of these trials is MND-SMART which is designed to run for several years and give more people with the disease a chance to take part in a trial. The MND…
Reading Time: 5 minutes The pace of MND research continues to increase, with more clinical trials underway in the UK, over the last year, than ever before. Adding to this momentum, the clinical platform trial MAGNET (Multi-arm, Adaptive, Group-sequential trial NETwork)has just opened to recruitment in the UK.
Over the last several decades, there have been over 140 clinical trials for MND and unfortunately most of these have not led to effective treatments. More recently, clinical trial design has become more innovative, including the use of platform trials. MAGNET is a platform trial which aims to accelerate the development of new potential treatments for MND by testing multiple drugs simultaneously.
Reading Time: 4 minutes A new clinical trial, investigating Dazucorilant, for the treatment of MND is now open for recruitment in the UK. With this trial, there are now 6 clinical trials recruiting in the UK, further highlighting the current momentum in finding potential effective treatments for MND. People living with MND often show signs of over-active adrenal glands,…
Reading Time: 2 minutes Researchers from King’s College London have recently completed a study looking into different variations (a change or mistake) within the SOD1 gene and found that understanding the position and type of change within the gene can help to predict onset and progression of the disease.
Reading Time: 2 minutes This blog is part of our Symposium Blogathon series – where we are counting down to the 33rd International Symposium. Throughout November we’ve been counting down to the 33rd International Symposium on ALS/MND, being held virtually from the 6- 9 of December, and we have reached our penultimate blog in this series. We hope you’ve joined…
